Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

This study has been terminated.
(lack of accrual)
Sponsor:
Information provided by (Responsible Party):
Sandeep Soni, M.D., Nationwide Children's Hospital
ClinicalTrials.gov Identifier:
NCT00874315
First received: April 1, 2009
Last updated: August 12, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)